SLC5A2 and metabolic dysfunction-associated steatohepatitis: In fact, mounting evidence suggests that certain types of anti-diabetic agents, such as inhibitors of sodium glucose cotransporter 2 (SGLT2) and dipeptidyl peptidase-4 (DPP-4), effectively ameliorate histologic parameters of NASH in mice and humans1–3.